Study Information for participants: Investigating a potential new oral treatment for Panic Disorder
Quick Reference:
What is the purpose of this study?
Where is my nearest study site?
What is the purpose of this study?
This study aims to evaluate the safety and effectiveness of a potential new oral treatment for Panic Disorder in adults between 18-65 years of age.
Where is my nearest study site?
Here is a list of all the sites who are currently recruiting for this study:
TBC
Who can participate?
To take part in this study, you will need to meet all the following:
- Aged between 18-65
- Diagnosis of Panic Disorder or struggling with recurring panic attacks
- Willing to comply with contraception requirements
- Willing to remain on current doses of other psychiatric medications throughout the length of the trial
Who cannot participate?
Unfortunately, if any of the following apply to you, this study is not the right fit for you:
- History of severe agoraphobia
- Currently pregnant or breastfeeding
- Recent participation in a clinical trial (prior 3 months)
- Severe uncontrolled cardiac disease within 6 months of screening
Please note, additional eligibility criteria apply and will be discussed in a phone call with our team.
What is involved?
If you are deemed eligible for the study, your participation is expected to last approximately 15 weeks. This includes:
- 6 visits to the study site
- 8 video calls
- 1 phone call
What is Panic Disorder?
Panic Disorder is characterized by experiencing symptoms like a feeling of discomfort, increased fear or sense of loss of control when there is no clear trigger. Physical symptoms people experience include trembling, rapid heart rate or sweating among many others.
Why is this study important?
This study will aim to improve symptoms associated with Panic Disorder and will aim to develop a potential new oral treatment option targeting areas where there are not currently available treatments for Panic Disorder. In time, potentially providing an alternative treatment option for Panic Disorder.
Who is involved?
This study is being sponsored by HB Biotech Pty Ltd.
Ready to register? Click here to sign up/login to Evrilink and start your clinical trial journey.
Still have questions? Use the form below and one of our patient experience team members will be in touch to assist with your enquiry!